ReviewFrontiers in medicine2022

Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.

Jan Marsal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.